Afya Limited (AFYA) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Afya Limited (AFYA) Consumer Business Overview

Afya Limited, a Brazilian medical education group, provides educational programs and digital health services to medical students and professionals. With a focus on lifelong learning, Afya operates a significant network of medical school campuses and offers a diverse range of courses, positioning itself as a key player in Brazil's medical education sector.

What Is the Investment Thesis for AFYA?

With a P/E ratio of 8.36 and a profit margin of 20.3%, Afya demonstrates solid financial performance. The company's expansion of its digital health services and continued growth in medical school seats are key growth drivers. The dividend yield of 4.72% provides an attractive income component for investors. However, potential regulatory changes in the Brazilian education sector and increased competition could pose risks. Investors should monitor Afya's ability to maintain its market share and adapt to evolving industry dynamics.

Based on FMP financials and quantitative analysis

AFYA Key Highlights

Market capitalization of $1.23B, reflecting Afya's significant presence in the Brazilian medical education market.

• P/E ratio of 8.36, indicating a potentially undervalued stock compared to its earnings.
• Profit margin of 20.3%, showcasing strong profitability in the education sector.
• Gross margin of 64.5%, demonstrating efficient cost management and pricing strategies.
• Dividend yield of 4.72%, offering an attractive income stream for investors.

Who Are AFYA's Competitors?

AFYA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are AFYA's Key Strengths?

Strong market position in Brazil's medical education sector.

• Comprehensive range of educational programs and services.
• Extensive network of medical school campuses.
• Growing digital health services platform.

What Are AFYA's Weaknesses?

Concentration of operations in Brazil.

• Dependence on regulatory approvals for new medical school seats.
• Exposure to economic fluctuations in Brazil.
• Potential for increased competition in the education sector.

What Could Drive AFYA Stock Higher?

Expansion of digital health services, driving recurring revenue and subscriber growth.

• Activation of approved medical school seats, increasing student enrollment and tuition revenue.
• Strategic acquisitions of smaller medical education institutions, expanding geographic reach and market share.
• Development and launch of new postgraduate programs, catering to specialized medical fields.
• Partnerships with hospitals and healthcare providers, enhancing clinical training opportunities for students.

What Are the Key Risks for AFYA?

Insider selling — insiders were net sellers of roughly $3.9M recently.

• Changes in government regulations affecting medical education, impacting tuition fees and accreditation standards.
• Increased competition from other education providers, potentially reducing market share and student enrollment.
• Economic downturns impacting student enrollment and affordability of education.
• Technological disruptions in the education sector, requiring continuous investment in innovation and adaptation.
• Fluctuations in the Brazilian currency, affecting the company's financial performance and international investors.

What Are the Growth Opportunities for AFYA?

• Expansion of Digital Health Services: Afya has the opportunity to further expand its digital health services, including its subscription-based mobile app and website portal. The market for digital health solutions is growing rapidly, with a projected market size of $9 billion in Brazil by 2028. By enhancing its digital offerings with new features and content, Afya can attract more subscribers and generate recurring revenue. This expansion can be achieved within the next 2-3 years, leveraging Afya's existing technology infrastructure and partnerships.
• Increasing Medical School Seats: Afya can increase its number of medical school seats to meet the growing demand for medical professionals in Brazil. The company currently has 278 approved seats that are not yet operational. By investing in infrastructure and faculty, Afya can activate these seats and expand its student base. The timeline for this growth is within the next 1-2 years, as regulatory approvals are already in place. The expansion of medical school seats will directly contribute to increased tuition revenue and long-term growth.
• Acquisition of Smaller Institutions: Afya can pursue strategic acquisitions of smaller medical education institutions in Brazil to expand its geographic reach and market share. The Brazilian education market is fragmented, with numerous smaller players that could be attractive acquisition targets. By acquiring these institutions, Afya can integrate their programs and students into its network, creating synergies and economies of scale. This growth strategy can be implemented over the next 3-5 years, focusing on institutions with strong reputations and complementary offerings.
• Development of New Postgraduate Programs: Afya can develop new postgraduate programs in specialized medical fields to cater to the evolving needs of healthcare professionals. The demand for specialized medical training is increasing, driven by advancements in medical technology and treatment methods. By offering postgraduate programs in areas such as cardiology, oncology, and neurology, Afya can attract experienced medical professionals seeking to enhance their skills and knowledge. These programs can be developed and launched within the next 2-4 years, leveraging Afya's existing faculty and resources.
• Partnerships with Hospitals and Healthcare Providers: Afya can form partnerships with hospitals and healthcare providers to offer clinical training opportunities for its students. These partnerships would provide students with valuable hands-on experience and exposure to real-world medical settings. By collaborating with leading healthcare institutions, Afya can enhance the quality of its medical education programs and improve the career prospects of its graduates. These partnerships can be established over the next 1-3 years, creating a mutually beneficial relationship between Afya and the healthcare industry.

What Are AFYA's Competitive Advantages?

• Strong brand reputation in the Brazilian medical education market.
• Extensive network of medical school campuses across Brazil.
• Comprehensive range of educational products and services.
• Proprietary digital health platform and content.
• Accredited medical programs and experienced faculty.

What Does AFYA Do?

Founded in 1999 and headquartered in Nova Lima, Brazil, Afya Limited has evolved into a prominent medical education group. The company offers a wide array of educational products and services, including undergraduate and graduate medical programs, medical residency preparatory courses, and other specialized programs tailored for medical learners at all stages of their careers. Afya also provides digital health services through subscription-based mobile apps and web portals, offering tools and resources to assist healthcare professionals in clinical decision-making. Afya's educational offerings extend beyond medicine to include health sciences courses such as dentistry, nursing, radiology, and pharmacy, as well as degree programs in business administration, law, and engineering. As of December 31, 2021, Afya operated a network of 46 undergraduate and graduate medical school campuses, comprising 30 operating units and 5 approved units, supporting 2,731 medical school seats, with 2,481 operating seats and 278 approved seats. This extensive infrastructure enables Afya to serve a large student population across Brazil, solidifying its position as a leader in the country's medical education landscape.

What Products and Services Does AFYA Offer?

• Offers undergraduate and graduate medical programs.
• Provides medical residency preparatory courses.
• Delivers digital health services through mobile apps and web portals.
• Offers health sciences courses, including dentistry, nursing, and pharmacy.
• Provides degree programs in business administration, law, and engineering.
• Offers medical postgraduate specialization programs.
• Provides printed and digital content for medical education.
• Offers an online medical education platform and practical medical training services.

How Does AFYA Make Money?

• Generates revenue through tuition fees from medical and health science programs.
• Earns subscription revenue from digital health services.
• Sells printed and digital educational content.
• Partnerships with third-party medical schools.

What Industry Does AFYA Operate In?

Afya Limited operates within the growing education and training services industry in Brazil, specifically focusing on medical education. The demand for healthcare professionals in Brazil is increasing, driving the need for quality medical education. The industry is competitive, with both public and private institutions vying for students. Afya distinguishes itself through its comprehensive educational offerings, digital health services, and extensive network of campuses. The market is expected to continue growing, driven by demographic trends and government initiatives to improve healthcare access.

Who Are AFYA's Key Customers?

• Medical students pursuing undergraduate and graduate degrees.
• Healthcare professionals seeking continuing education and training.
• Medical residents preparing for specialization exams.
• Third-party medical schools utilizing Afya's educational resources.

Afya Limited (AFYA) Valuation Context

Valued at $1.23B, AFYA is classified as a small-cap stock. Analyst price targets span from $16.00 to $18.00, with a consensus of $16.75. At the current price of $13.63, that implies approximately 23% upside potential. Relative to its peer group, AFYA's quantitative score of 94/100 is above the peer average of 71/100.

AFYA Revenue & Earnings Trend

In Jun 2026, AFYA generated $195.0M in top-line revenue, marking a sequential increase of 0.0%. The company recorded net income of $39.5M, with diluted EPS of $0.44. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this small-cap Consumer Defensive company. Across the four most recent quarters, AFYA averaged $0.43 in diluted EPS.

Company Profile

Afya Limited operates in the Education & Training Services industry within the Consumer Defensive sector. It is headquartered in Belo Horizonte, BR. The company is led by CEO Virgilio Deloy Capobianco Gibbon. AFYA has traded publicly since 2019.

Return on equity for Afya Limited stands at 16.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 7.9%, showing how much profit it generates from its asset base. AFYA trades at a trailing price-to-earnings ratio of 8.36, below the Consumer Defensive sector average of ~27.60x. Its free cash flow yield is 18.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.78 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 12.0%, the inverse of the P/E and a quick read on earnings relative to price.

Afya Limited's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 2.30 places it in the grey zone, a middle ground that warrants monitoring.

Afya Limited has beaten Wall Street's EPS estimate in 6 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 7.8% above estimates on average.

Wall Street analysts project Afya Limited revenue of about $4.03B for fiscal 2026, with EPS near $9.19. The estimate reflects 5 contributing analysts.

Over the past six months, Afya Limited insiders filed 57 SEC Form 4 transactions — 46 sales and 11 purchases. On net that is roughly 234K shares disposed (about $3.9M), a signal worth weighing alongside the fundamentals.

AFYA Financials

AFYA Latest News

AFYA Analyst Consensus

AFYA MoonshotScore

Afya Limited Consumer Defensive Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources